With TOR, Less is more: a key role for the conserved nutrient-sensing TOR pathway in Aging

Buck Institute for Age Research, 8001 Redwood Boulevard, Novato, CA 94945, USA.
Cell metabolism (Impact Factor: 17.57). 06/2010; 11(6):453-65. DOI: 10.1016/j.cmet.2010.05.001
Source: PubMed


Target of rapamycin (TOR) is an evolutionarily conserved nutrient-sensing protein kinase that regulates growth and metabolism in all eukaryotic cells. Studies in flies, worms, yeast, and mice support the notion that the TOR signaling network modulates aging. TOR is also emerging as a robust mediator of the protective effects of various forms of dietary restriction (DR), which can extend life span and slow the onset of certain age-related diseases across species. Here we discuss how modulating TOR signaling slows aging through downstream processes including mRNA translation, autophagy, endoplasmic reticulum (ER) stress signaling, stress responses, and metabolism. Identifying the mechanisms by which the TOR signaling network works as a pacemaker of aging is a major challenge and may help identify potential drug targets for age-related diseases, thereby facilitating healthful life span extension in humans.

Download full-text


Available from: Subhash D Katewa, Dec 17, 2013
  • Source
    • "A reduction in protein synthetic burden may preserve proteostasis by limiting the accumulation of misfolded and/or damaged proteins, possibly by increasing translational fidelity, chaperone capacity, and/or proteolytic capacity (Hipkiss, 2007; Kapahi et al., 2010; Conn & Qian, 2013; Sherman & Qian, 2013). In addition, when global protein synthesis is inhibited, differential translational upregulation of mRNAs encoding proteins involved in somatic maintenance and stress responses has been reported (Yamasaki & Anderson, 2008; Kapahi et al., 2010). Conversely, a primary reduction in damage to proteins, induction of chaperone synthesis, or a primary increase in proteolytic capacity (i.e., improved editing) could improve proteostasis independently of the absolute rate of protein synthesis in tissues. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Combating the social and economic consequences of a growing elderly population will require the identification of interventions that slow the development of age-related diseases. Preserved cellular homeostasis and delayed aging have been previously linked to reduced cell proliferation and protein synthesis rates. To determine whether changes in these processes may contribute to or predict delayed aging in mammals, we measured cell proliferation rates and the synthesis and replacement rates (RRs) of over a hundred hepatic proteins in vivo in three different mouse models of extended maximum lifespan (maxLS): Snell Dwarf, calorie-restricted (CR), and rapamycin (Rapa)-treated mice. Cell proliferation rates were not consistently reduced across the models. In contrast, reduced hepatic protein RRs (longer half-lives) were observed in all three models compared to controls. Intriguingly, the degree of mean hepatic protein RR reduction was significantly correlated with the degree of maxLS extension across the models and across different Rapa doses. Absolute rates of hepatic protein synthesis were reduced in Snell Dwarf and CR, but not Rapa-treated mice. Hepatic chaperone levels were unchanged or reduced and glutathione S-transferase synthesis was preserved or increased in all three models, suggesting a reduced demand for protein renewal, possibly due to reduced levels of unfolded or damaged proteins. These data demonstrate that maxLS extension in mammals is associated with improved hepatic proteome homeostasis, as reflected by a reduced demand for protein renewal, and that reduced hepatic protein RRs hold promise as an early biomarker and potential target for interventions that delay aging in mammals.
    Aging cell 11/2015; DOI:10.1111/acel.12414 · 6.34 Impact Factor
  • Source
    • "Direct genetic manipulations of mTOR pathway components or downstream targets can alter lifespan in many different organisms, whereas treatment with rapamycin, an inhibitor of mTOR, has been shown to increase lifespan in yeast, worms, flies and, even in mice when initiated late in life (Bjedov et al., 2010; Blagosklonny, 2013; Kapahi et al., 2010; Vellai et al., 2003). Interestingly, at the metabolic and molecular level, mTOR inactivation mimics the effects of dietary restriction (DR), a reduction in nutrient intake without malnutrition (Kapahi et al., 2010). DR prolongs lifespan and opposes the late-onset disability and diseases, in diverse species, whereas studies in primates indicate that DR provides an overall health benefit (Mirzaei et al., 2014). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Messenger RNA (mRNA) turnover that determines the lifetime of cytoplasmic mRNAs is a means to control gene expression under both normal and stress conditions, whereas its impact on ageing and age-related disorders has just become evident. Gene expression control is achieved at the level of the mRNA clearance as well as mRNA stability and accessibility to other molecules. All these processes are regulated by cis-acting motifs and trans-acting factors that determine the rates of translation and degradation of transcripts. Specific messenger RNA granules that harbor the mRNA decay machinery or various factors, involved in translational repression and transient storage of mRNAs, are also part of the mRNA fate regulation. Their assembly and function can be modulated to promote stress resistance in adverse conditions and over time affect the ageing process and the lifespan of the organism. Here, we provide insights into the complex relationships of ageing modulators and mRNA turnover mechanisms.
    Mechanisms of ageing and development 10/2015; 152. DOI:10.1016/j.mad.2015.09.006 · 3.40 Impact Factor
  • Source
    • "IGF and insulin pathways are activated via their cognate membrane receptors inducing a signaling cascade centered in the AKT family of protein kinases that is related to a reduction in life span in model organisms (Miyauchi et al. 2004). On the other hand, the nutrient-dependent activation of mTOR pathway induces a metabolic alteration toward cell growth upon regulation of catabolism mediated by autophagy (Kapahi et al. 2010). Inhibition of this pathway extends life span in model organisms and confers protection against a wide range of age-related pathologies (Johnson et al. 2013). "
    [Show abstract] [Hide abstract]
    ABSTRACT: Aging is a universal phenomenon in metazoans, characterized by a general decline of the organism physiology associated with an increased risk of mortality and morbidity. Aging of an organism correlates with a decline in function of its cells, as shown for muscle, immune, and neuronal cells. As the DNA content of most cells within an organism remains largely identical throughout the life span, age-associated transcriptional changes must be achieved by epigenetic mechanisms. However, how aging may impact on the epigenetic state of cells is only beginning to be understood. In light of a growing number of studies demonstrating that noncoding RNAs can provide molecular signals that regulate expression of protein-coding genes and define epigenetic states of cells, we hypothesize that noncoding RNAs could play a direct role in inducing age-associated profiles of gene expression. In this context, the role of long noncoding RNAs (lncRNAs) as regulators of gene expression might be important for the overall transcriptional landscape observed in aged human cells. The possible functions of lncRNAs and other noncoding RNAs, and their roles in the regulation of aging-related cellular pathways will be analyzed.
    Current topics in microbiology and immunology 07/2015; DOI:10.1007/82_2015_460 · 4.10 Impact Factor
Show more